Pfizer vs DBS Group Holdings Ltd
Comparação do valor de mercado ao longo do tempo
Pfizer
$155.3B
Posição #113
DBS Group Holdings Ltd
$159.4B
Posição #110
Valor de mercado ao longo do tempo
Momentos-chave
- DBS Group Holdings Ltd ultrapassou Pfizer até 2026
Comparação ano a ano
| Ano | Pfizer | DBS Group Holdings Ltd | Líder |
|---|---|---|---|
| 2026 | $155.3B | $159.4B | DBS Group Holdings Ltd |
| 2025 | $137.3B | $115.1B | Pfizer |
| 2024 | $136.4B | $84.1B | Pfizer |
| 2023 | $139.5B | $55.1B | Pfizer |
| 2022 | $237.5B | $52.2B | Pfizer |
| 2021 | $265.1B | $48.1B | Pfizer |
| 2020 | $159.1B | $36.0B | Pfizer |
| 2019 | $154.3B | $35.1B | Pfizer |
| 2018 | $165.8B | $30.4B | Pfizer |
| 2017 | $132.8B | $30.1B | Pfizer |
| 2016 | $114.6B | $20.4B | Pfizer |
| 2015 | $109.7B | $18.8B | Pfizer |
| 2014 | $102.5B | $22.6B | Pfizer |
| 2013 | $97.3B | $18.1B | Pfizer |
| 2012 | $77.1B | $15.2B | Pfizer |
| 2011 | $64.0B | $11.4B | Pfizer |
| 2010 | $49.7B | $13.6B | Pfizer |
| 2009 | $49.6B | $14.4B | Pfizer |
| 2008 | $45.8B | $7.5B | Pfizer |
| 2007 | $55.2B | $17.5B | Pfizer |
| 2006 | $60.1B | $18.4B | Pfizer |
| 2005 | $52.1B | $12.9B | Pfizer |
| 2004 | $58.3B | $12.1B | Pfizer |
| 2003 | $75.0B | $10.8B | Pfizer |
| 2002 | $63.7B | $7.8B | Pfizer |
| 2001 | $81.9B | $9.6B | Pfizer |
| 2000 | $93.5B | $13.2B | Pfizer |